Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus pyogenes cell envelope proteinase (SpyCEP), also known as ScpC, is a large surface-exposed serine protease expressed by Group A Streptococcus (GAS). Its primary biological function is the highly specific cleavage and inactivation of CXC chemokines, most notably interleukin-8 (IL-8/CXCL8), which is a potent chemoattractant for neutrophils (Zinkernagel et al., 2008, Cell Host & Microbe). By degrading these signaling molecules, SpyCEP prevents the recruitment of neutrophils to the site of infection, allowing the bacteria to evade the host's innate immune response and disseminate into deeper tissues (Kurupati et al., 2010, Journal of Biological Chemistry). This mechanism is particularly critical in the pathogenesis of severe, invasive infections such as necrotizing fasciitis and streptococcal toxic shock syndrome. As a major virulence factor, SpyCEP is considered a promising therapeutic target for the development of vaccines and neutralizing antibodies aimed at restoring host immune clearance (Turner et al., 2009, Journal of Infectious Diseases). Experimental strategies focus on inhibiting its proteolytic activity to ensure that chemokine gradients remain intact, thereby facilitating an effective inflammatory response against the pathogen.
Inhibition of the protease activity to prevent the cleavage of CXC chemokines like IL-8, thereby restoring neutrophil recruitment to the site of infection.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pyogenes cell envelope proteinase (SpyCEP).